(NASDAQ:ASND), COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones. Ascendis President and CEO Jan Mikkelsen will present this update on Monday, January 12, during the 44th Annual J.P. Morgan Healthcare Conference. “With our proven TransCon(R) technology […]

(NYSE:ITGR), NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integer Holdings Corporation (NYSE: ITGR) between July 25, 2024 and October 22, 2025, both dates inclusive (the “Class Period”), of the important February 9, 2026 lead plaintiff deadline. SO WHAT:

Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference – Rapidly transforming into a leading global biopharma company GlobeNewswire January 09, 2026 COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones.

ROSEN, A TOP-RANKED LAW FIRM, Encourages Integer Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ITGR GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integer Holdings Corporation (NYSE: ITGR)

(TSX-V:RECO),(OTC US:RECAF),(Other OTC:RECAF),(Boerse Frankfurt – Freiverkehr:0XD), CALGARY, Alberta, Jan. 09, 2026 (GLOBE NEWSWIRE) — Reconnaissance Energy Africa Ltd. (the “Company”, “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) announces that the Board of Directors of the Company has adopted a Shareholder Rights Plan with Odyssey Trust Company as Rights Agent effective today. The Shareholder

(NASDAQ:SLNO), NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE

NEW YORK CITY, NY / ACCESS Newswire / January 9, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

ReconAfrica Announces Adoption of Shareholder Rights Plan GlobeNewswire January 09, 2026 CALGARY, Alberta, Jan. 09, 2026 (GLOBE NEWSWIRE) — Reconnaissance Energy Africa Ltd. (the “Company”, “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) announces that the Board of Directors of the Company has adopted a Shareholder Rights Plan with Odyssey Trust Company as Rights

SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors concerning the Company's and/or members of its senior management's possible violation

(NasdaqGM:GAUZ), NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gauzy Ltd. (NASDAQ: GAUZ) between March 11, 2025 and November 13, 2025, both dates inclusive (the “Class Period”), of the important February 6, 2026 lead plaintiff deadline. SO WHAT: If you